initial products
Equine Gastric Ulcer Treatment
ODT is developing a product for the treatment of equine gastric ulcers . The product has significant initial clinical data and is expected to be on the market in 2027.
Equine Gastic Ulcer Preventative
ODT is concurrently developing a product for the prevention of equine gastric ulcers . The product would be administered daily and is also expected to be on the market in 2027.
Rapid / Concurrent Development
The ODT team is leveraging considerable prior studies to advance these two products and expects to have both registered by the FDA CVM in 36 months.
Established Manufacturing
ODT has partnered with a manufacturer of human products. Our partner has successfully launched over 35 orally disintegrating products globally and is currently making over 1.2 billion tablets per year for human markets.